ASCO GUIDELINES Bundle

Dyspnea in Advanced Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475459

Contents of this Issue

Navigation

Page 5 of 13

6 Treatment Table 1. Definitions Term Definition Advanced cancer e American Cancer Society defines advanced cancer as "cancers that cannot be cured" and metastatic cancer as tumors that "have usually spread from where they started to other parts of the body." However, not all advanced cancers are metastatic. For example, brain tumors may be considered advanced because they are oen not curable, even in the absence of metastasis. In this guideline, particular emphasis was placed on studies including patients with advanced cancer. Other patient populations were also considered when formulating the recommendations. Dyspnea e American oracic Society defines dyspnea as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity." In this guideline, dyspnea is considered to be equivalent to "breathlessness" and "air hunger." High Flow Nasal Cannula (HFNC) Delivers a humidified, heated, air oxygen blend (allowing from 21%– 100% fraction of inspired oxygen) generating up to 60 liters/minute flow rates through a large diameter nasal cannula. Hypercapnia PaCO 2 ≥45 mmHg Hypoxemia Oxygen saturation (SpO 2 ) <90% while breathing room air at rest, which is equivalent to PaO 2 of <60 mmHg. Morphine equivalent daily dose (MEDD) e total dose of opioid use per 24-hour period, taking into account both the scheduled and rescue doses. To facilitate this calculation, different opioids can be converted to oral morphine equivalents using standardized ratios. 15 mg of oral morphine is equivalent to 3.75 mg of oral hydromorphone, 5 mg of oral oxymorphone, 10 mg of oral oxycodone and 15 mg of hydrocodone. Parenteral opioids are generally 2–3× as strong as their oral counterparts. Non-invasive ventilation e American oracic Society and European Respiratory Society Guideline defines non-invasive ventilation as "noninvasive variable positive airway pressure (most commonly 'bilevel') devices consisting of a higher inspiratory positive airway pressure and a lower expiratory pressure as well as continuous positive airway pressure (CPAP) delivered using various nasal, oronasal, and facial interfaces." Standard supplemental oxygen Conventional oxygen therapy delivered via nasal cannula or face masks — can achieve flow rates of up to 15 liters/minute.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Dyspnea in Advanced Cancer